1. Home
  2. IMNM vs MTUS Comparison

IMNM vs MTUS Comparison

Compare IMNM & MTUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • MTUS
  • Stock Information
  • Founded
  • IMNM 2006
  • MTUS 1899
  • Country
  • IMNM United States
  • MTUS United States
  • Employees
  • IMNM N/A
  • MTUS N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • MTUS
  • Sector
  • IMNM Health Care
  • MTUS
  • Exchange
  • IMNM Nasdaq
  • MTUS NYSE
  • Market Cap
  • IMNM 747.7M
  • MTUS 699.0M
  • IPO Year
  • IMNM 2020
  • MTUS N/A
  • Fundamental
  • Price
  • IMNM $12.01
  • MTUS $15.79
  • Analyst Decision
  • IMNM Strong Buy
  • MTUS
  • Analyst Count
  • IMNM 5
  • MTUS 0
  • Target Price
  • IMNM $28.60
  • MTUS N/A
  • AVG Volume (30 Days)
  • IMNM 803.1K
  • MTUS 442.0K
  • Earning Date
  • IMNM 11-13-2024
  • MTUS 11-07-2024
  • Dividend Yield
  • IMNM N/A
  • MTUS N/A
  • EPS Growth
  • IMNM N/A
  • MTUS N/A
  • EPS
  • IMNM N/A
  • MTUS 0.53
  • Revenue
  • IMNM $10,129,000.00
  • MTUS $1,171,600,000.00
  • Revenue This Year
  • IMNM N/A
  • MTUS N/A
  • Revenue Next Year
  • IMNM N/A
  • MTUS $8.76
  • P/E Ratio
  • IMNM N/A
  • MTUS $29.42
  • Revenue Growth
  • IMNM N/A
  • MTUS N/A
  • 52 Week Low
  • IMNM $7.76
  • MTUS $13.83
  • 52 Week High
  • IMNM $30.96
  • MTUS $24.31
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 43.70
  • MTUS 50.19
  • Support Level
  • IMNM $12.99
  • MTUS $15.51
  • Resistance Level
  • IMNM $15.13
  • MTUS $17.70
  • Average True Range (ATR)
  • IMNM 0.93
  • MTUS 0.49
  • MACD
  • IMNM -0.16
  • MTUS -0.13
  • Stochastic Oscillator
  • IMNM 3.79
  • MTUS 20.51

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About MTUS METALLUS INC

Metallus Inc is an America-based manufacturer of alloy steel, as well as carbon and micro-alloy steel. The portfolio of the company includes special bar quality steel, seamless mechanical tubes, and value-add solutions, such as precision steel components. The company also supplies machining and thermal treatment services and manages raw material recycling programs that work as a feeder system for its melt operations. The company's products and services are used in the following sectors: oil and gas; automotive; industrial equipment; mining; construction; rail; aerospace and defense; heavy truck; agriculture; and power generation. Geographically, the company mainly serves customers in the United States.

Share on Social Networks: